اضافه کردن مدیلیب به صفحه اصلی
Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups. The journal encourages the submission of unsolicited review articles.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟